Lothar Lindemann

3.9k total citations
38 papers, 2.8k citations indexed

About

Lothar Lindemann is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Lothar Lindemann has authored 38 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 20 papers in Cellular and Molecular Neuroscience and 10 papers in Genetics. Recurrent topics in Lothar Lindemann's work include Receptor Mechanisms and Signaling (15 papers), Neuroscience and Neuropharmacology Research (12 papers) and Genetics and Neurodevelopmental Disorders (10 papers). Lothar Lindemann is often cited by papers focused on Receptor Mechanisms and Signaling (15 papers), Neuroscience and Neuropharmacology Research (12 papers) and Genetics and Neurodevelopmental Disorders (10 papers). Lothar Lindemann collaborates with scholars based in Switzerland, United States and Germany. Lothar Lindemann's co-authors include Marius C. Hoener, Joseph G. Wettstein, Georg Jaeschke, Will Spooren, Mark F. Bear, Laurence Ozmen, Aubin Michalon, Theresa M. Ballard, Michael S. Sidorov and Luca Santarelli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and Nature Neuroscience.

In The Last Decade

Lothar Lindemann

34 papers receiving 2.7k citations

Peers

Lothar Lindemann

CMN

GENET

Terrell T. Gibbs United States

Theresa M. Ballard Switzerland

Tatiana V. Lipina Canada

Niels Plath Denmark

Robert H. Ring United States

Timothy M. DeLorey United States

David H. Farb United States

Liam Drew United Kingdom

Yukio Ago Japan

Stacey J. Sukoff Rizzo United States

Terrell T. Gibbs United States

Lothar Lindemann

1.6k ×1.1

2.3k ×1.9

CMN

635 ×0.7

GENET

723 ×0.8

189 ×0.9

Citations per year, relative to Lothar Lindemann Lothar Lindemann (= 1×) peers Terrell T. Gibbs

Countries citing papers authored by Lothar Lindemann

Since Specialization

Citations

This map shows the geographic impact of Lothar Lindemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lothar Lindemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lothar Lindemann more than expected).

Fields of papers citing papers by Lothar Lindemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lothar Lindemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lothar Lindemann. The network helps show where Lothar Lindemann may publish in the future.

Co-authorship network of co-authors of Lothar Lindemann

This figure shows the co-authorship network connecting the top 25 collaborators of Lothar Lindemann. A scholar is included among the top collaborators of Lothar Lindemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lothar Lindemann. Lothar Lindemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garringer, Holly J., Liliana D. Pedro, Dennis Crusius, et al.. (2025). γ-Secretase modulator resistance of an aggressive Alzheimer-causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compounds. Alzheimer s Research & Therapy. 17(1). 49–49. 1 indexed citations

Tzouros, Manuel, Jens Lamerz, Angélique Augustin, et al.. (2020). Symmetric signal transduction and negative allosteric modulation of heterodimeric mGlu1/5 receptors. Neuropharmacology. 190. 108426–108426. 18 indexed citations

Youssef, Eriene, Elizabeth Berry‐Kravis, Christian Czech, et al.. (2017). Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results. Neuropsychopharmacology. 43(3). 503–512. 93 indexed citations

Delporte, Marie‐Laure, Scott Schobel, Lothar Lindemann, et al.. (2017). Results and evaluation of a first‐in‐human study of RG7342, an mGlu5 positive allosteric modulator, utilizing Bayesian adaptive methods. British Journal of Clinical Pharmacology. 84(3). 445–455. 7 indexed citations

Berry‐Kravis, Elizabeth, Lothar Lindemann, Aia Elise Jønch, et al.. (2017). Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nature Reviews Drug Discovery. 17(4). 280–299. 233 indexed citations

Steullet, Pascal, Joseph T. Coyle, Michael Didriksen, et al.. (2017). Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia. Molecular Psychiatry. 22(7). 936–943. 273 indexed citations

Peterlik, Daniel, Anna Bludau, Dominic Schmidt, et al.. (2016). Blocking metabotropic glutamate receptor subtype 5 relieves maladaptive chronic stress consequences. Brain Behavior and Immunity. 59. 79–92. 14 indexed citations

Scharf, Sebastian H., Georg Jaeschke, Joseph G. Wettstein, & Lothar Lindemann. (2014). Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome. Current Opinion in Pharmacology. 20. 124–134. 84 indexed citations

Michalon, Aubin, Andreas Bruns, Céline Risterucci, et al.. (2013). Chronic Metabotropic Glutamate Receptor 5 Inhibition Corrects Local Alterations of Brain Activity and Improves Cognitive Performance in Fragile X Mice. Biological Psychiatry. 75(3). 189–197. 48 indexed citations

10.

Rantamäki, Tomi, Susanna Kemppainen, Henri Autio, et al.. (2013). The Impact of Bdnf Gene Deficiency to the Memory Impairment and Brain Pathology of APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease. PLoS ONE. 8(7). e68722–e68722. 45 indexed citations

11.

Higashimori, Haruki, et al.. (2013). Astroglial FMRP-dependent translational down-regulation of mGluR5 underlies glutamate transporter GLT1 dysregulation in the fragile X mouse. Human Molecular Genetics. 22(10). 2041–2054. 62 indexed citations

12.

Spooren, Will, Lothar Lindemann, Anirvan Ghosh, & Luca Santarelli. (2012). Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders. Trends in Pharmacological Sciences. 33(12). 669–684. 100 indexed citations

13.

Salomons, Amber R., Hetty Boleij, Susanne Kirchhoff, et al.. (2012). Differential effects of diazepam and MPEP on habituation and neuro-behavioural processes in inbred mice. Behavioral and Brain Functions. 8(1). 30–30. 13 indexed citations

14.

Ullmer, Christoph, Sannah Zoffmann, Bernd Bohrmann, et al.. (2012). Functional monoclonal antibody acts as a biased agonist by inducing internalization of metabotropic glutamate receptor 7. British Journal of Pharmacology. 167(7). 1448–1466. 20 indexed citations

15.

Lindemann, Lothar, Georg Jaeschke, Aubin Michalon, et al.. (2011). CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 339(2). 474–486. 91 indexed citations

16.

Kratochwil, Nicole A., Marius C. Hoener, Lothar Lindemann, et al.. (2011). G Protein-Coupled Receptor Transmembrane Binding Pockets and their Applications in GPCR Research and Drug Discovery: A Survey. Current Topics in Medicinal Chemistry. 11(15). 1902–1924. 17 indexed citations

17.

Autio, Henri, Kert Mätlik, Tomi Rantamäki, et al.. (2011). Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus. Neuropharmacology. 61(8). 1291–1296. 44 indexed citations

18.

Lindholm, Jesse, Henri Autio, Liisa Vesa, et al.. (2011). The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf+/− heterozygous null mice. Neuropharmacology. 62(1). 391–397. 83 indexed citations

19.

Lindemann, Lothar, Claas A. Meyer, Karine Jeanneau, et al.. (2007). Trace Amine-Associated Receptor 1 Modulates Dopaminergic Activity. Journal of Pharmacology and Experimental Therapeutics. 324(3). 948–956. 258 indexed citations

20.

Lindemann, Lothar, Martin Ebeling, Nicole A. Kratochwil, et al.. (2005). Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. Genomics. 85(3). 372–385. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact